EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, DaVita's enterprise value is $21,736 Mil.
DaVita's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $2,321 Mil. Therefore, DaVita's EV-to-EBITDA for today is 9.36.
The historical rank and industry rank for DaVita's EV-to-EBITDA or its related term are showing as below:
DVA'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.29 Med: 10.38 Max: 14.78
Current: 9.36
During the past 13 years, the highest EV-to-EBITDA of DaVita was 14.78. The lowest was 6.29. And the median was 10.38.
DVA's EV-to-EBITDA is ranked better than 65.36% of 459
companies
in the Healthcare Providers & Services industry
Industry Median: 12.81
vs DVA: 9.36
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-19), DaVita's stock price is $126.11.
DaVita's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $7.400. Therefore, DaVita's PE Ratio for today is 17.04.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
DaVita EV-to-EBITDA Historical Data
The historical data trend for DaVita's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
DaVita Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
EV-to-EBITDA
9.26
11.22
9.73
9.61
9.36
DaVita Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-EBITDA
9.61
9.85
10.85
9.59
9.36
Competitive Comparison
For the Medical Care Facilities subindustry, DaVita's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DaVita EV-to-EBITDA Distribution
For the Healthcare Providers & Services industry and Healthcare sector, DaVita's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where DaVita's EV-to-EBITDA falls into.
DaVita's current Enterprise Value is $21,736 Mil.
DaVita's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,321 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DaVita (NYSE:DVA) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
DaVita's share price for today is $126.11.
DaVita's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.400.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of DaVita's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DVA has been successfully added to your 